Provided by Tiger Trade Technology Pte. Ltd.

Labcorp Holdings Inc

308.11
-0.7000-0.23%
Post-market: 308.200.0900+0.03%19:30 EDT
Volume:646.18K
Turnover:199.56M
Market Cap:24.93B
PE:25.51
High:311.54
Open:311.00
Low:306.98
Close:308.81
52wk High:341.80
52wk Low:244.52
Shares:80.90M
Float Shares:80.50M
Volume Ratio:0.83
T/O Rate:0.80%
Dividend:2.88
Dividend Rate:0.93%
EPS(TTM):12.08
EPS(LYR):10.46
ROE:11.73%
ROA:5.53%
PB:2.90
PE(LYR):29.46

Loading ...

Evercore ISI Remains a Buy on Labcorp Holdings (LH)

TIPRANKS
·
Sep 11

UBS Adjusts Labcorp Price Target to $380 From $361, Maintains Buy Rating

MT Newswires Live
·
Sep 11

Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH)

TIPRANKS
·
Sep 11

Labcorp price target raised to $380 from $361 at UBS

TIPRANKS
·
Sep 11

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (LH) and Edwards Lifesciences (EW)

TIPRANKS
·
Sep 11

Labcorp price target raised to $330 from $320 at Barclays

TIPRANKS
·
Sep 11

U.S. Research Roundup- Adobe, Chewy, Mosaic

Reuters
·
Sep 11

Centene Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 11

Labcorp Backs Guidance, Forecasts Further Growth Ahead

Dow Jones
·
Sep 10

Labcorp provides long-term outlook through 2029

TIPRANKS
·
Sep 10

GUIDANCE: (LH) Labcorp Expects 2026 Adjusted EPS Range $18.10 to $18.55

MT Newswires Live
·
Sep 10

Labcorp Reaffirms 2026 Adjusted EPS Outlook of $18.10-$18.55

Reuters
·
Sep 10

Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day

THOMSON REUTERS
·
Sep 10

Labcorp - Expects 5%-8% Cagr Revenue and 8.5%-11.5% Cagr Adj EPS Through 2029

THOMSON REUTERS
·
Sep 10

Labcorp - Reaffirms Full-Year 2026 Guidance

THOMSON REUTERS
·
Sep 10

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 10

Stray Alerts from NYSE Pre-Market Update Tagged to Multiple Companies Withdrawn

Reuters
·
Sep 09

Genfit Posts MASH Diagnostics Technology Presentation

Reuters
·
Sep 09

IQVIA Sees U.S. MASH Diagnostics Using Genfit Technology Topping USD 1.5 Billion Sales by 2033

Reuters
·
Sep 09

Centene Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09